Integra LifeSciences Holdings Corporation (IART)
| Previous close | 28.41 |
| Open | 28.42 |
| Bid | 28.34 x 600 |
| Ask | 28.51 x 200 |
| Day's range | 28.39 - 28.81 |
| 52-week range | 27.18 - 56.21 |
| Volume | |
| Avg. volume | 769,611 |
| Market cap | 2.232B |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | 33.80 |
| EPS (TTM) | 0.84 |
| Earnings date | 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 44.40 |
GlobeNewswireIntegra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT. A live webcast will be available on the Investors section of the Company’s website at investor.integr
ZacksEdwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksEarnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
